Why?

Despite being the most commonly detected electrolyte abnormality occurring in SAH patients, no national guidelines have been developed to directly address the management of hyponatremia following SAH.

Furthermore, the specific impact of hyponatremia on SAH outcomes has not yet been defined, due to inconsistency and bias across studies. This audit seeks to establish a national baseline through a UK-wide, hospital-based audit of screening, investigation, and management of hyponatremia following SAH.

This is an excellent opportunity for involvement in neurosurgery, endocrinology, and in audit.

All consultants, trainees, or medical students contributing to data collection will receive credit with collaborator status on all publications.